In the single-arm FULCRUM-VT trial, 59% of patients remained free of recurrent VT at 6 months, with less amiodarone use.

A major international trial led by the University of British Columbia found that starting treatment with catheter-based pulsed field ablation offers better rhythm control than medication for patients ...

The "father of modern cardiology" Eugene Braunwald, MD, died at the age of 96, and he was honored with obituaries from the ...

Two retrospective studies detected arrhythmias beyond 48 hours in 30% of patients post cardiac ablation and in 60% of ...

Over the last weekend, Chicago played host to the 2026 edition of the Heart Rhythm Society's annual conference (HRS 2026).

A common heart condition called atrial fibrillation, often shortened to AFib, affects millions of people around the world. It ...

Pulse Biosciences ( (PLSE)) just unveiled an update. On April 25, 2026, Pulse Biosciences reported updated late‑breaking data from its first‑in‑human feasibility study of the nPulse Cardiac Catheter ...

Seminole County's best source of news since 1908. This local newspaper covers Sanford, Lake Mary, Altamonte Springs, Longwood ...

The AVANT GUARD trial found that first-line pulsed field ablation (PFA) reduced atrial arrhythmia recurrence more than antiarrhythmic drugs in persistent atrial fibrillation. At 12 months, 56% of PFA ...

Medtronic announces key Affera clinical study milestones for Sphere-9 and Sphere-360 catheters as global adoption continues: Galway, Ireland Tuesday, April 28, 2026, 11:00 Hrs [IS ...

A minimally invasive heart procedure may be a better first-line treatment than medication for people living with advanced ...